These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3002534)

  • 1. Biochemical markers and skeletal metabolism in carcinoma of the prostate. Use of decision matrix theory and ROC analysis.
    Urwin GH; Percival RC; Yates AJ; Watson ME; Couch M; McDonald B; Forrest AR; Williams JL; Kanis JA
    Br J Urol; 1985 Dec; 57(6):711-4. PubMed ID: 3002534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum osteocalcin concentration in patients with prostatic cancer.
    Francini G; Bigazzi S; Leone V; Gennari C
    Am J Clin Oncol; 1988; 11 Suppl 2():S83-7. PubMed ID: 3266542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical prediction of response of bone metastases to treatment.
    Coleman RE; Whitaker KB; Moss DW; Mashiter G; Fogelman I; Rubens RD
    Br J Cancer; 1988 Aug; 58(2):205-10. PubMed ID: 3262366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone turnover markers in tumor pathology with bone involvement].
    Napal Lecumberri J; Amado Señarís JA; Pesquera C; Riancho JA; González Macías J
    Med Clin (Barc); 1990 Apr; 94(13):487-9. PubMed ID: 2355762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.
    Stĕpán JJ; Presl J; Broulík P; Pacovský V
    J Clin Endocrinol Metab; 1987 May; 64(5):1079-82. PubMed ID: 3031119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
    Rinsho K; Aoyagi K
    Tohoku J Exp Med; 1982 Aug; 137(4):461-2. PubMed ID: 7123546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary and serum hydroxyproline in the diagnosis of bone metastases of prostatic cancer].
    Gasser AB; Jeannet C; Depierre D; Courvoisier B
    Schweiz Med Wochenschr; 1981 Feb; 111(8):246-51. PubMed ID: 7233140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on bone metabolism of urological tumors forming metastases.
    Bichler KH; Petri E; Hub A; Kleinknecht S; Heidenreich A
    Urol Int; 1996; 56(2):61-8. PubMed ID: 8659012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indices of calcium metabolism in women with hip fractures.
    Cooper C; Mclaren M; Wood PJ; Coulton L; Kanis JA
    Bone Miner; 1989 Jan; 5(2):193-200. PubMed ID: 2784069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease.
    Pecherstorfer M; Zimmer-Roth I; Schilling T; Woitge HW; Schmidt H; Baumgartner G; Thiébaud D; Ludwig H; Seibel MJ
    J Clin Endocrinol Metab; 1995 Jan; 80(1):97-103. PubMed ID: 7829646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
    Charles P; Poser JW; Mosekilde L; Jensen FT
    J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum osteocalcin in hyperthyroidism].
    Roiter I; Legovini P; Da Rin G; Galliazzo S; Di Virgilio R; Foscolo G; Breda F; Conte N
    Ann Ital Med Int; 1990; 5(2):95-9. PubMed ID: 2248865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteocalcin, a marker in diseases with elevated bone metabolism].
    Stracke H; Schatz C; Pralle H; Ullmann J; Schatz H
    Dtsch Med Wochenschr; 1985 Sep; 110(38):1442-6. PubMed ID: 3875469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal tubular reabsorption of phosphate is positively related to the extent of bone metastatic load in patients with prostate cancer.
    Buchs N; Bonjour JP; Rizzoli R
    J Clin Endocrinol Metab; 1998 May; 83(5):1535-41. PubMed ID: 9589651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine hydroxyproline excretion--a marker of bone metastases in prostatic carcinoma.
    Bishop MC; Fellows GJ
    Br J Urol; 1977; 49(7):711-6. PubMed ID: 597712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of 1,25 dihydroxyvitamin D, alkaline phosphatase, hydroxyproline, and osteocalcin associated with antler growth in white-tailed deer.
    Van der Eems KL; Brown RD; Gundberg CM
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):407-14. PubMed ID: 3260707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical picture of bone metabolism in breast cancer patients with bone metastases.
    Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A
    Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a short course of estrogen on mineral metabolism in postmenopausal women.
    Stock JL; Coderre JA; Mallette LE
    J Clin Endocrinol Metab; 1985 Oct; 61(4):595-600. PubMed ID: 2993339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical picture accompanying sclerotic bone metastases of prostatic origin.
    Minisola S; Perugia G; Scarda A; Scarnecchia L; Tuzzolo D; Rossi W; Mazzuoli G
    Br J Urol; 1987 Nov; 60(5):443-6. PubMed ID: 3427318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological markers of bone metabolism].
    Delmas PD
    Presse Med; 1993 Feb; 22(6):263-8. PubMed ID: 8511145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.